ORMP ORAMED PHARMACEUTICALS INC Investments/Divestments 8-K Filing 2024 - Agreement for Stock Offering Oramed Pharmaceuticals Inc. entered into an at the market offering agreement with Rodman & Renshaw LLC and StockBlock Securities LLC to issue and sell shares of its common stock with a maximum aggregate offering price of up to $75,000,000.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC